Department of Clinical Pharmacy

Medicine & Life Sciences

1. 4-phenylenediamine 20%
2. Acute Kidney Injury 20%
3. Acute Lung Injury 15%
4. Advanced Glycation End Products 16%
5. Anemia 16%
6. anti-endothelial cell antibody 22%
7. Antipsychotic Agents 100%
8. Aprepitant 20%
9. Aripiprazole 64%
10. Asenapine 37%
11. Benzodiazepines 15%
12. Bipolar Disorder 52%
13. Blood Pressure 17%
14. Cancer Pain 16%
15. Carboplatin 36%
16. Chronic Renal Insufficiency 26%
17. Cisplatin 62%
18. Confidence Intervals 17%
19. Contact Dermatitis 16%
20. Coronavirus 17%
21. Databases 30%
22. Deltoid Muscle 19%
23. Depression 19%
24. Desvenlafaxine Succinate 19%
25. Drug Therapy 36%
26. Drug-Related Side Effects and Adverse Reactions 31%
27. Elderly 31%
28. Erlotinib Hydrochloride 20%
29. favipiravir 49%
30. Febrile Neutropenia 17%
31. Febuxostat 21%
32. Fluvoxamine 25%
33. fosaprepitant 25%
34. Hair Dyes 21%
35. Hematinics 19%
36. Hemoglobins 19%
37. Hypersensitivity 15%
38. Hyperuricemia 21%
39. Ifosfamide 17%
40. Immune Reconstitution 18%
41. Immunoglobulin G 22%
42. Induced Pluripotent Stem Cells 15%
43. Injections 48%
44. Interstitial Lung Diseases 30%
45. Ipilimumab 16%
46. Japan 46%
47. Kidney 27%
48. Lamotrigine 17%
49. Lansoprazole 15%
50. Lithium 41%
51. Lung Neoplasms 17%
52. Lupus Nephritis 16%
53. Lymphoma 22%
54. Lymphoma, Large B-Cell, Diffuse 19%
55. Machine Learning 15%
56. Maintenance 23%
57. Major Depressive Disorder 21%
58. Meglumine 21%
59. Meta-Analysis 44%
60. Myelodysplastic Syndromes 15%
61. Nephritis 20%
62. Network Meta-Analysis 36%
63. Nivolumab 51%
64. Observational Studies 23%
65. Odds Ratio 33%
66. Olanzapine 35%
67. Outpatients 17%
68. Oxycodone 18%
69. Paliperidone Palmitate 17%
70. pembrolizumab 27%
71. Pemetrexed 18%
72. Pharmaceutical Preparations 37%
73. Pharmacists 31%
74. Pharmacology 18%
75. Pharmacovigilance 17%
76. Placebos 38%
77. Polypharmacy 33%
78. Prescription Drugs 18%
79. Propensity Score 32%
80. Proton Pump Inhibitors 15%
81. Quetiapine Fumarate 22%
82. Randomized Controlled Trials 38%
83. Recurrence 32%
84. Retrospective Studies 45%
85. Risperidone 20%
86. Safety 29%
87. Salvage Therapy 16%
88. Schizophrenia 80%
89. Serotonin Plasma Membrane Transport Proteins 17%
90. Serum 20%
91. Serum Albumin 17%
92. Severe Acute Respiratory Syndrome 17%
93. Sleep Initiation and Maintenance Disorders 17%
94. suvorexant 24%
95. Systematic Reviews 40%
96. Tamoxifen 15%
97. Therapeutics 43%
98. Uric Acid 19%
99. Vortioxetine 19%
100. XELOX 22%